Jupiter Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
517,666
+29,079
| +6% | +$631K | 0.09% | 222 |
|
|
2025
Q1 | $11.8M | Buy |
488,587
+6,600
| +1% | +$160K | 0.11% | 208 |
|
|
2024
Q4 | $10.1M | Sell |
481,987
-217,957
| -31% | -$4.55M | 0.1% | 226 |
|
|
2024
Q3 | $13.9M | Sell |
699,944
-41,731
| -6% | -$830K | 0.12% | 197 |
|
|
2024
Q2 | $11.5M | Sell |
741,675
-67,685
| -8% | -$1.05M | 0.11% | 194 |
|
|
2024
Q1 | $12.9M | Sell |
809,360
-34,571
| -4% | -$551K | 0.12% | 196 |
|
|
2023
Q4 | $14.2M | Sell |
843,931
-53,115
| -6% | -$893K | 0.14% | 181 |
|
|
2023
Q3 | $10.5M | Buy |
897,046
+350,184
| +64% | +$4.09M | 0.12% | 197 |
|
|
2023
Q2 | $7.34M | Sell |
546,862
-876,722
| -62% | -$11.8M | 0.08% | 243 |
|
|
2023
Q1 | $23.6M | Buy |
1,423,584
+1,376,339
| +2,913% | +$22.8M | 0.33% | 97 |
|
|
2022
Q4 | $878K | Buy |
47,245
+879
| +2% | +$16.3K | 0.01% | 376 |
|
|
2022
Q3 | $595K | Buy |
46,366
+15,679
| +51% | +$201K | 0.01% | 423 |
|
|
2022
Q2 | $215K | Buy |
+30,687
| New | +$215K | ﹤0.01% | 549 |
|